1.37
price down icon2.14%   -0.03
after-market 시간 외 거래: 1.37
loading

VolitionRX Ltd 주식(VNRX)의 최신 뉴스

pulisher
Jun 10, 2026

VolitionRx Enters Securities Purchase Agreement With Investors to Raise Capital - TradingView

Jun 10, 2026
pulisher
Jun 09, 2026

VolitionRx (NYSE: VNRX) prices $4.6M stock offering with $2.3M warrant upside - Stock Titan

Jun 09, 2026
pulisher
Jun 09, 2026

VolitionRx (NYSE: VNRX) to Offer 2.96M Shares and 1.48M Warrants - Stock Titan

Jun 09, 2026
pulisher
Jun 08, 2026

VolitionRx stock tumbles on $4.6M offering priced at discount By Investing.com - Investing.com Nigeria

Jun 08, 2026
pulisher
Jun 08, 2026

VolitionRx prices $4.6 million public offering at $1.55 per share By Investing.com - Investing.com Australia

Jun 08, 2026
pulisher
Jun 07, 2026

VolitionRx prices $4.6 million public offering at $1.55 per share - Investing.com

Jun 07, 2026
pulisher
Jun 07, 2026

VolitionRx Announces Pricing of $4.6 Million Public Offering - marketscreener.com

Jun 07, 2026
pulisher
Jun 07, 2026

Epigenetics firm VolitionRx prices $4.6M deal with $2.3M in potential warrant proceeds - Stock Titan

Jun 07, 2026
pulisher
Jun 05, 2026

VolitionRx (VNRX) files shelf prospectus for stock, detachable warrants - Stock Titan

Jun 05, 2026
pulisher
Jun 04, 2026

H.C. Wainwright cuts VolitionRX stock price target to $1 on share count - Investing.com

Jun 04, 2026
pulisher
Jun 03, 2026

New Ebola triage blood test: VolitionRx seeks partners for outbreak zones - Stock Titan

Jun 03, 2026
pulisher
Jun 03, 2026

VolitionRx Files Patent for Nu.Q NETs Test in Ebola Triage and Monitoring - Moomoo

Jun 03, 2026
pulisher
Jun 02, 2026

VolitionRx (NYSE: VNRX) seeks approval to cut authorized shares and add 2026 stock plan - Stock Titan

Jun 02, 2026
pulisher
Jun 02, 2026

Benchmark reiterates Hold on VolitionRX stock amid milestones By Investing.com - Investing.com South Africa

Jun 02, 2026
pulisher
Jun 02, 2026

Benchmark reiterates Hold on VolitionRX stock amid milestones - Investing.com

Jun 02, 2026
pulisher
Jun 01, 2026

VolitionRx Ltd stock (US92852X1037): shares trade quietly after May earnings update - AD HOC NEWS

Jun 01, 2026
pulisher
May 29, 2026

VolitionRX (VNRX) Insider Trading Activity 2026 - MarketBeat

May 29, 2026
pulisher
May 28, 2026

VolitionRx : Short Corporate Deck, May 2026 - marketscreener.com

May 28, 2026
pulisher
May 28, 2026

VNRX Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

May 28, 2026
pulisher
May 27, 2026

VolitionRx reports 300% Q1 revenue growth, nears vet milestone By Investing.com - Investing.com South Africa

May 27, 2026
pulisher
May 27, 2026

VolitionRx reports 300% Q1 revenue growth, nears vet milestone - Investing.com

May 27, 2026
pulisher
May 27, 2026

VolitionRx Highlights Commercial Momentum and Multi-Pillar Execution Across $27+ Billion Total Addressable Markets - Moomoo

May 27, 2026
pulisher
May 26, 2026

VolitionRX Limited (VNRX) Slides 6% as Stock Tests Key Support LevelsParabolic SAR - newsline.com

May 26, 2026
pulisher
May 24, 2026

VolitionRx Limited (VNRX): 7 Best Rated Penny Stocks to Buy According to Wall Street Analysts - Yahoo Finance UK

May 24, 2026
pulisher
May 23, 2026

VolitionRx Limited Files Form 8-K With SEC Detailing Company Information and NYSE Listing - Minichart

May 23, 2026
pulisher
May 22, 2026

VolitionRx receives waiver on market capitalization covenant from Lind Global - Investing.com

May 22, 2026
pulisher
May 22, 2026

VolitionRx Obtains Covenant Waiver on $9.9 Million Convertible Notes From Lind, Avoiding Acceleration - TradingView

May 22, 2026
pulisher
May 22, 2026

Covenant breach leads VolitionRx (NYSE: VNRX) to secure Lind waiver and note changes - Stock Titan

May 22, 2026
pulisher
May 20, 2026

VolitionRX Earnings Call: Breakthrough Science, Cash Burn Risk - TipRanks

May 20, 2026
pulisher
May 20, 2026

VolitionRX Earnings Call Balances Breakthroughs and Risks - TipRanks

May 20, 2026
pulisher
May 16, 2026

VolitionRx Limited (AMEX:VNRX) Q1 2026 Earnings Call Transcript - Insider Monkey

May 16, 2026
pulisher
May 15, 2026

VolitionRX Ltd (VNRX) Q1 2026 Earnings Call Highlights: Revenue Surge and Strategic Partnerships Propel Growth - GuruFocus

May 15, 2026
pulisher
May 15, 2026

VolitionRx director Mickie Henshall to step down, board size to be reduced - Investing.com Australia

May 15, 2026
pulisher
May 15, 2026

VolitionRx director Mickie Henshall to step down, board size to be reduced By Investing.com - Investing.com South Africa

May 15, 2026
pulisher
May 15, 2026

Mickie Henshall to Leave Volition Board; Company to Reduce Board Size - TradingView

May 15, 2026
pulisher
May 15, 2026

VolitionRx (VNRX) director exits at 2026 meeting as board shrinks to seven - Stock Titan

May 15, 2026
pulisher
May 15, 2026

Lagoda holds 17.07M VolitionRX shares after amendment (VNRX) - Stock Titan

May 15, 2026
pulisher
May 15, 2026

Earnings call transcript: VolitionRx Q1 2026 sees revenue surge, EPS miss - Investing.com

May 15, 2026
pulisher
May 15, 2026

Full Transcript: VolitionRX Q1 2026 Earnings Call - Benzinga

May 15, 2026
pulisher
May 15, 2026

Q1 2026 VolitionRX Ltd Earnings Call Transcript - GuruFocus

May 15, 2026
pulisher
May 14, 2026

Is VolitionRX (VNRX) a Value Trap After Q1 2026? EPS Not Disclos - GuruFocus

May 14, 2026
pulisher
May 14, 2026

VolitionRX: Q1 Earnings Snapshot - marketscreener.com

May 14, 2026
pulisher
May 14, 2026

VolitionRx Ltd stock (US92852X1037): Q1 2026 update and epigenetics business profile - AD HOC NEWS

May 14, 2026
pulisher
May 14, 2026

Rising revenue but cash risk at VolitionRx (NYSE: VNRX) in Q1 2026 - Stock Titan

May 14, 2026
pulisher
May 14, 2026

VolitionRx (NYSE: VNRX) lifts Q1 2026 revenue and secures new funding - Stock Titan

May 14, 2026
pulisher
May 14, 2026

Cat cancer blood test may unlock $5M payout for VolitionRx - Stock Titan

May 14, 2026
DGX DGX
$197.76
price down icon 1.63%
MTD MTD
$1,129.53
price down icon 1.91%
$159.09
price down icon 3.16%
IQV IQV
$170.67
price down icon 4.74%
$226.44
price up icon 2.88%
WAT WAT
$357.00
price down icon 0.98%
자본화:     |  볼륨(24시간):